All articles tagged with #signos
The FDA has approved Signos' glucose monitoring system for weight loss, offering an accessible, AI-driven solution that uses continuous glucose monitors to provide real-time data and personalized recommendations, aiming to help Americans manage their weight more effectively and affordably.
Signos is a startup offering a subscription service that includes a small continuous glucose monitor (CGM) and an app that aims to help users lose weight by tracking their blood sugar. The CGM, which is not intended for diabetes management, sends data to the app to provide personalized insights into how the body responds to specific foods and daily habits like diet, exercise, stress, and sleep. While the platform offers valuable insights, it comes with a high price tag and may not be covered by insurance for non-diabetic users. Users should be mindful of their mental health and consult with a doctor before using the technology.